ACTIVE

PHARMA PLUS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

15,9 k €

-79.7% YoY

Gross margin

248,4 k €

-58.8% YoY

Equity

876 k €

+1.8% YoY

Workforce

4,1 ETP

-2.4% YoY

What does PHARMA PLUS do?

PHARMA PLUS is a Private limited company incorporated in 1987. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Boussu. It employs on average 4,1 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0432.850.028

Incorporation

21/12/1987

Legal form

Private limited company

Registered office

Rue Alfred Dendal(B) 192
7300 Boussu · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

4,1 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	248,4 k €	-58.8%	602,9 k €	+32.9%	453,8 k €	-6.1%	483,5 k €	+10.7%	436,8 k €	+6.7%	409,3 k €	+4.3%	392,3 k €	-16.9%	472,1 k €	-5.8%	501 k €	-20.2%	627,6 k €	+141%	260,9 k €	-1.3%	264,3 k €	-11.8%	299,7 k €	+31.3%	228,2 k €	-20.0%	285,2 k €	+23.7%	230,5 k €	-24.3%	304,3 k €	-2.1%	310,9 k €	+5.2%	295,5 k €	-0.4%	296,7 k €
EBITDA	23,9 k €	-93.8%	387 k €	+215%	122,7 k €	-33.5%	184,5 k €	+34.7%	137 k €	+441%	25,3 k €	-73.8%	96,8 k €	-53.6%	208,7 k €	-11.8%	236,6 k €	-39.3%	390,1 k €	+639%	52,8 k €	-28.7%	74 k €	-36.3%	116,2 k €	+106%	56,4 k €	-45.5%	103,5 k €	+41.0%	73,4 k €	-50.2%	147,4 k €	-6.6%	157,8 k €	+3.1%	153,1 k €	-1.5%	155,4 k €
Operating result	12,1 k €	-87.3%	95,2 k €	+35.0%	70,5 k €	-44.0%	125,9 k €	+65.9%	75,9 k €	+361%	-29 k €	-175%	38,7 k €	-69.5%	127 k €	-16.3%	151,8 k €	-55.6%	342,1 k €	+12207%	2,8 k €	-84.4%	17,8 k €	-68.1%	56 k €	+518%	-13,4 k €	-134%	39,1 k €	+795%	-5,6 k €	-109%	65,1 k €	-19.4%	80,8 k €	-6.8%	86,7 k €	-4.9%	91,1 k €
Net result	15,9 k €	-79.7%	78,4 k €	+53.8%	50,9 k €	-45.0%	92,7 k €	+68.9%	54,9 k €	+283%	-30 k €	-234%	22,4 k €	-70.9%	76,7 k €	-10.7%	85,9 k €	-60.4%	216,9 k €	+3500%	-6,4 k €	-213%	5,7 k €	-85.3%	38,3 k €	+259%	-24,1 k €	-370%	8,9 k €	+139%	-22,6 k €	-169%	32,6 k €	-14.2%	38 k €	-5.0%	40 k €	+3.9%	38,5 k €
Balance sheet
Equity	876 k €	+1.8%	860,2 k €	+10.0%	781,8 k €	-28.9%	1,1 M €	+9.2%	1 M €	+5.8%	951,3 k €	-3.1%	981,3 k €	+2.3%	958,9 k €	+8.7%	882,2 k €	+10.8%	796,3 k €	+37.4%	579,4 k €	-1.1%	585,8 k €	+1.0%	580,1 k €	-0.3%	581,8 k €	-4.0%	605,8 k €	+1.5%	596,9 k €	-3.6%	619,5 k €	+5.6%	586,9 k €	+6.9%	548,9 k €	+7.9%	508,9 k €
Total assets	1 M €	-2.0%	1 M €	-2.7%	1,1 M €	-18.7%	1,3 M €	+10.8%	1,2 M €	+5.5%	1,1 M €	-16.5%	1,4 M €	-7.0%	1,5 M €	+0.8%	1,4 M €	+3.6%	1,4 M €	+79.4%	779 k €	-11.1%	876,2 k €	-8.2%	954,3 k €	-1.3%	966,7 k €	-7.1%	1 M €	-3.9%	1,1 M €	-1.9%	1,1 M €	-1.5%	1,1 M €	+3.8%	1,1 M €	-4.3%	1,1 M €
Cash	5,4 k €	-1.9%	5,5 k €	-53.6%	11,8 k €	-11.9%	13,4 k €	+92.1%	7 k €	-10.8%	7,8 k €	-51.5%	16,2 k €	+84.7%	8,7 k €	-48.0%	16,8 k €	-2.0%	17,2 k €	-91.1%	193,1 k €	-1.6%	196,3 k €	-10.5%	219,4 k €	+24.1%	176,7 k €	+3.1%	171,4 k €	+17.7%	145,7 k €	+7.3%	135,8 k €	-24.9%	180,8 k €	+14.5%	157,9 k €	+36.9%	115,3 k €
Debts	152,3 k €	-19.5%	189,1 k €	-36.2%	296,3 k €	+30.9%	226,5 k €	+19.0%	190,3 k €	+4.0%	182,9 k €	-51.5%	377,4 k €	-24.7%	501,5 k €	-11.5%	566,3 k €	-5.8%	601,4 k €	+201%	199,6 k €	-31.1%	289,8 k €	-22.4%	373,5 k €	-2.8%	384,2 k €	-11.3%	433,3 k €	-10.7%	485,4 k €	+0.3%	484,1 k €	-9.4%	534 k €	+0.6%	530,8 k €	-14.3%	619,2 k €
Other
Workforce	4,1 ETP	-2.4%	4,2 ETP	-28.8%	5,9 ETP	+5.4%	5,6 ETP	-13.8%	6,5 ETP	0.0%	6,5 ETP	0.0%	6,5 ETP	+4.8%	6,2 ETP	-4.6%	6,5 ETP	+16.1%	5,6 ETP	0.0%	5,6 ETP	+14.3%	4,9 ETP	+6.5%	4,6 ETP	0.0%	4,6 ETP	0.0%	4,6 ETP	0.0%	4,6 ETP	0.0%	4,6 ETP	0.0%	4,6 ETP	0.0%	4,6 ETP	0.0%	4,6 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 13 ended

Active mandates

ALEXO

Chairman of the board of directors · since 01 septembre 2022 · 0870.896.286

Represented by Olivier Delaere

Active

SODIAP

Managing director · since 22 décembre 2020 · 0405.366.364

Represented by Tom Goderis

Active

Ended mandates

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · until 31 août 2022 · 0434.718.564

Represented by Frank Coene

Ended

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · 0434.718.564

Represented by Frank Coene

Ended

Frank Coene

Chairman of the board of directors · since 29 février 2016 · until 22 décembre 2020

Ended

Frank Coene

Chairman of the board of directors · since 29 février 2016

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/05/2026	17/06/2025	12/06/2024	09/06/2023	07/06/2022	14/06/2021
General meeting	03/04/2026	04/04/2025	05/04/2024	07/04/2023	01/04/2022	03/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	03/04/2026	12/05/2026	French	PDF
Abridged model	31/12/2024	04/04/2025	17/06/2025	French	PDF
Abridged model	31/12/2023	05/04/2024	12/06/2024	French	PDF
Abridged model	31/12/2022	07/04/2023	09/06/2023	French	PDF
Abridged model	31/12/2021	01/04/2022	07/06/2022	French	PDF
Abridged model	31/12/2020	03/06/2021	14/06/2021	French	PDF
Abridged model	31/12/2019	04/06/2020	14/07/2020	French	PDF
Abridged model	31/12/2018	06/06/2019	09/07/2019	French	PDF
Abridged model	31/12/2017	07/06/2018	28/06/2018	French	PDF
Abridged model	31/12/2016	01/06/2017	10/07/2017	Dutch	PDF
Abridged model	31/12/2015	02/06/2016	24/08/2016	French	PDF
Abridged model	31/12/2014	17/05/2015	27/08/2015	French	PDF
Abridged model	31/12/2013	18/04/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	19/04/2013	29/08/2013	French	PDF
Abridged model	31/12/2011	20/04/2012	30/08/2012	French	PDF
Abridged modelCorrection	31/12/2010	22/04/2011	19/09/2011	French	PDF
Abridged model	31/12/2010	22/04/2011	26/08/2011	French	PDF
Abridged model	31/12/2009	24/04/2010	30/09/2010	French	PDF
Abridged model	31/12/2008	25/04/2009	22/06/2009	French	PDF
Abridged model	31/12/2007	26/04/2008	30/05/2008	French	PDF
Abridged model	31/12/2006	28/04/2007	19/06/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 13 ended

Active mandates

ALEXO

Chairman of the board of directors · since 01 septembre 2022 · 0870.896.286

Represented by Olivier Delaere

Active

SODIAP

Managing director · since 22 décembre 2020 · 0405.366.364

Represented by Tom Goderis

Active

Ended mandates

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · until 31 août 2022 · 0434.718.564

Represented by Frank Coene

Ended

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · 0434.718.564

Represented by Frank Coene

Ended

Frank Coene

Chairman of the board of directors · since 29 février 2016 · until 22 décembre 2020

Ended

Frank Coene

Chairman of the board of directors · since 29 février 2016

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates14/12/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates25/03/2021
DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Mandates16/03/2016
DEMISSIONS, NOMINATIONS
PDF
Restructuring24/07/2013
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates13/12/2011
DEMISSIONS, NOMINATIONS
PDF
Mandates28/09/2005
DEMISSIONS, NOMINATIONS
PDF
Restructuring10/07/2003
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring08/04/2003
DIVERS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202515,9 k €↓
2024
Annual accounts 202478,4 k €↑
2024
Name change046 - Pharma Plus
2023
Annual accounts 202350,9 k €↓
2022
Annual accounts 202292,7 k €↑
2021
Annual accounts 202154,9 k €↑
2021
Name changePharma Plus
2020
Annual accounts 2020-30 k €↓
2019
Annual accounts 201922,4 k €↓
2018
Annual accounts 201876,7 k €↓
2017
Annual accounts 201785,9 k €↓
2016
Annual accounts 2016216,9 k €↑
2015
Annual accounts 2015-6,4 k €↓
2014
Annual accounts 20145,7 k €↓
2013
Annual accounts 201338,3 k €↑
2012
Annual accounts 2012-24,1 k €↓
2011
Annual accounts 20118,9 k €↑
2010
Annual accounts 2010-22,6 k €↓
2009
Annual accounts 200932,6 k €↓
2008
Annual accounts 200838 k €↓
2007
Annual accounts 200740 k €↑
2006
Annual accounts 200638,5 k €
21/12/1987
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA PLUS

Overview

What does PHARMA PLUS do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline